Cargando…

Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism

HCC has remained one of the challenging cancers to treat, owing to the paucity of drugs targeting the critical survival pathways. Considering the cancer cells are deficient in DNase activity, the increase of an autonomous apoptisis endonuclease should be a reasonable choice for cancer treatment. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Yusha, Yang, Kang, Liu, Pengpeng, Ma, Dong, Lei, Ping, Liu, Quanyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692146/ https://www.ncbi.nlm.nih.gov/pubmed/34975319 http://dx.doi.org/10.7150/ijbs.57919

Ejemplares similares

Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis
por: Gu, Yang, et al.
Publicado: (2020)

Plasma DNA and deoxyribonuclease are associated with glucose metabolism in healthy mice
por: Kmeťová, Katarína, et al.
Publicado: (2022)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

Structure of acid deoxyribonuclease
por: Varela-Ramirez, Armando, et al.
Publicado: (2017)

Deoxyribonucleases and Their Applications in Biomedicine
por: Lauková, Lucia, et al.
Publicado: (2020)

Role of Cell-Free DNA and Deoxyribonucleases in Tumor Progression
por: Alekseeva, Ludmila, et al.
Publicado: (2021)

A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma
por: Guo, Deliang, et al.
Publicado: (2021)

Activation of Deoxyribonucleases by Divalent Cations
por: Desreux, V., et al.
Publicado: (1962)

Recombinant Human Deoxyribonuclease I
por: Lazarus, Robert A., et al.
Publicado: (2019)

Integrative analysis of deoxyribonuclease 1-like 3 as a potential biomarker in renal cell carcinoma
por: Ge, Minghuan, et al.
Publicado: (2023)

New therapy of pleural empyema by deoxyribonuclease
por: Kacprzak, Grzegorz, et al.
Publicado: (2013)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

Deoxyribonuclease 1-like 3 may be a potential prognostic biomarker associated with immune infiltration in colon cancer
por: Liu, Jing, et al.
Publicado: (2021)

A novel role for synaptic acetylcholinesterase as an apoptotic deoxyribonuclease
por: Du, Aiying, et al.
Publicado: (2015)

Pan‑cancer analysis of the deoxyribonuclease gene family
por: Bai, Qingquan, et al.
Publicado: (2023)

S-Adenosyl-L-Methionine for the Treatment of Chronic Liver Disease: A Systematic Review and Meta-Analysis
por: Guo, Tao, et al.
Publicado: (2015)

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
por: Lei, Pan, et al.
Publicado: (2023)

Deoxyribonuclease from Salmon Testes : I. Purification and properties
por: McDonald, Margaret R.
Publicado: (1962)

Integration of Deoxyribonuclease-Treated DNA in Bacillus subtilis Transformation
por: Bodmer, Walter F.
Publicado: (1966)

PERIODIC INDUCTION OF DEOXYRIBONUCLEASE ACTIVITY IN RELATION TO THE MITOTIC CYCLE
por: Stern, Herbert
Publicado: (1961)

Cancer cell membrane-camouflaged MOF nanoparticles for a potent dihydroartemisinin-based hepatocellular carcinoma therapy
por: Xiao, Yusha, et al.
Publicado: (2020)

Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1
por: Liu, Pengpeng, et al.
Publicado: (2022)

METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression
por: Xia, Peng, et al.
Publicado: (2023)

A DEMONSTRATION OF SEVERAL DEOXYRIBONUCLEASE ACTIVITIES IN MAMMALIAN CELL MITOCHONDRIA
por: Durphy, Michael, et al.
Publicado: (1974)

Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases
por: Malíčková, Karin, et al.
Publicado: (2011)

Investigating the Deoxyribonuclease Activity of CRM197 with Site-Directed Mutagenesis
por: Bravo-Bautista, Nathalie, et al.
Publicado: (2019)

Purification and characterization of a novel ubiquitin-like antitumour protein with hemagglutinating and deoxyribonuclease activities from the edible mushroom Ramaria botrytis
por: Zhou, Rong, et al.
Publicado: (2017)

Mapping the metabolic reprogramming induced by sodium-glucose cotransporter 2 inhibition
por: Kogot-Levin, Aviram, et al.
Publicado: (2023)

Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma
por: Ma, Zhili, et al.
Publicado: (2019)

PERIODIC INCREASE IN DEOXYRIBONUCLEASE ACTIVITY DURING THE CELL CYCLE IN SYNCHRONIZED EUGLENA
por: Walther, William G., et al.
Publicado: (1970)

Purification and characterization of deoxyribonuclease from small intestine of camel Camelus dromedarius
por: Abdel-Gany, Somia S., et al.
Publicado: (2017)

Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung
por: King, Paul T., et al.
Publicado: (2017)

Fabrication of a Deoxyribonuclease Sensor Based on the Electrical Characteristics of DNA Molecules
por: Himuro, Takahiro, et al.
Publicado: (2022)

Editorial: Metabolic reprogramming and cancer progression
por: Yin, Qinan, et al.
Publicado: (2022)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Glucose metabolic reprogramming in autoimmune diseases
por: Jeong, Hoim, et al.
Publicado: (2023)

PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
por: Hu, Xiaomeng, et al.
Publicado: (2022)

Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism
por: Chen, Zhao, et al.
Publicado: (2021)

Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms
por: Xiao, Yusha, et al.
Publicado: (2019)

Targeting WDxR motif reprograms immune microenvironment and inhibits hepatocellular carcinoma progression
por: Zhang, Heng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hun4mjheu9pu4o6ukqoqlemck0